WillItSurvive
China · China

B&C Chemical

Chinese maker of photoresists and chemicals used to print circuits onto chips.

Losing its protection
Assessed 29 July 2026 · Evidence as of 29 July 2026
The structural protection is eroding.
On the recordSince 29 July 2026 · Checkable from 2031 (five years from March 2026 statement) · Every call on the record Checkpoint: Stated target for KrF/ArF advanced photoresist mass production
The call

B&C sits inside a market China is walling off for domestic players, but it still has to prove it can actually ship the advanced photoresist it has promised.

B&C Chemical makes photoresist, a chemical used to print tiny patterns on computer chips. China's government has blocked Japanese companies like Tokyo Ohka Kogyo and JSR from selling there, which gives B&C a protected home market. However, B&C has not yet shipped advanced products that customers need, while its rivals have proven track records and have already gone public; B&C has not disclosed new funding or a valuation since April 2023. The one thing that could change whether B&C matters is whether it files to go public within the next year or so at a strong price, which would signal that Chinese chip makers are betting on it as a real competitor.

Why
01
AI pressure: None apparent. AI chip demand could eventually pull more photoresist orders, but no AI product threatens this chemistry business today. Could AI do the core job? Unlikely.
02
Bigger players: Tokyo Ohka Kogyo, JSR, Shin-Etsu, Fujifilm, DuPont. These five firms hold most of the world's photoresist revenue and keep shipping working chips today while B&C still targets a five year roadmap. Could a giant copy it? No, they are blocked.
03
What protects it. China's export controls and 2026 supply-chain rules push domestic fabs toward Chinese suppliers, regardless of who is furthest along technically.
What would change this call
Whether Red Avenue's Hong Kong IPO (filed Feb 2026) completes and at what valuation. Shows if peers are setting a public-market template B&C has not yet matched.
Whether B&C ships verified KrF/ArF mass production by its stated March 2026 target. Tests if B&C can convert its five-year roadmap into shipped, fab-qualified product.
Whether B&C announces a new funding round or IPO filing at or above the $1.02B 2023 valuation. Shows if investors still value B&C as a leading domestic-substitution bet.
Key numbers
  • Valuation near $1.02B (2023-04-23)
  • Total funding about $170-177M across 8 rounds (2023-04-18)
  • Huawei's Hubble invested about $43.5M (2021-08)
Named risks
  • Advanced KrF/ArF photoresist remains a five-year roadmap, not shipped product, as of March 2026. Severity: high
  • No new funding round, valuation update, or IPO filing since April 2023, over three years stale. Severity: high
  • Domestic rivals Red Avenue and Hengkun have public listings and verified revenue growth B&C lacks. Severity: medium
  • Geopolitical thaw between Japan and China could reduce urgency for domestic photoresist substitution. Severity: medium
  • No verified revenue or headcount disclosure makes commercial scale unconfirmed. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Red Avenue New Materiallosing toRanked #1 Chinese photoresist supplier by revenue 9M 2025, filed Hong Kong IPO Feb 13 2026
Xiamen Hengkun New Materiallosing toListed on STAR Market Nov 18 2025 with KrF revenue up ~30x to RMB 13.52M by 2024
Jiangsu Nata Opto-electronic MaterialcontestingIC Fund-backed rival with existing ArF photoresist capacity as of Feb 2026
Tokyo Ohka Kogyo, JSR, Shin-Etsu, Fujifilm, DuPontgaining onBlocked from Chinese fabs by export controls and China's April 7 2026 supply-chain law, opening domestic share to B&C
Questions people ask
Is B&C Chemical profitable or does it disclose revenue?
No audited or press-reported revenue figures exist for B&C Chemical; as of April 2023, CB Insights' financial detail page for the company showed revenue fields blank or gated, and no update has surfaced through July 2026.
What is B&C Chemical's current valuation?
B&C Chemical was last valued at roughly $1.02 billion (RMB 7 billion post-money) after an April 2023 Series C-III round raising over RMB 600 million ($86.9M) co-led by Zhongping Capital and Guokai Technology Venture Investment. No newer valuation has been disclosed.
Can AI replace B&C Chemical's photoresist manufacturing?
No. B&C Chemical makes physical photoresist chemicals for chip fabs, a materials-science and precision-manufacturing business. AI can accelerate R&D and process optimization but cannot substitute for fab-grade chemical synthesis and multi-year qualification cycles.
Who is B&C Chemical's biggest competitor?
Domestically, Red Avenue New Material ranked #1 among Chinese photoresist suppliers by revenue for the first nine months of 2025 and filed for a Hong Kong IPO on February 13, 2026, outpacing B&C on commercial traction and capital markets access.
Has B&C Chemical shipped advanced KrF/ArF photoresists yet?
No. In March 2026, chairman Fu Zhiwei stated B&C aims to mass-produce advanced KrF and ArF photoresists within five years, meaning as of mid-2026 this remains a roadmap target, not shipped product, while peers like Red Avenue already report KrF revenue growth.
Is B&C Chemical planning an IPO?
No IPO filing has been announced for B&C Chemical as of July 2026, even as domestic peers moved ahead: Xiamen Hengkun listed on Shanghai's STAR Market on November 18, 2025, and Red Avenue filed for a Hong Kong IPO on February 13, 2026.
Timeline
  • 2026-04-07China's Regulations on Industrial and Supply Chain Security take effect, penalizing foreign firms
  • 2026-03-17Chairman Fu Zhiwei says B&C targets KrF/ArF photoresist mass production within five years
  • 2026-02-13Rival Red Avenue New Material files for Hong Kong IPO
  • 2025-11-18Rival Xiamen Hengkun New Material lists on Shanghai STAR Market
  • 2025-03JSR Corporation taken private by Japan Industrial Partners, consolidating EUV resist R&D
  • 2024B&C reports 14nm wet-process photoresist breakthrough and ~10x metal-impurity reduction
  • 2023-04-23B&C reaches unicorn status at ~$1.02B valuation after RMB 600M+ round
  • 2021-08Huawei's Hubble Technology invests roughly RMB 300 million (~$43.5M) in B&C
  • 2012B&C reportedly becomes only non-Japan-domestic supplier qualified by JSR
Revision history
29 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
MeituanShein GroupXiaomi Corporation
More in China →
Sources